These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23816477)

  • 1. Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
    Rahman M; Baimbridge C; Davis BR; Barzilay JI; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
    Clin Nephrol; 2013 Oct; 80(4):235-48. PubMed ID: 23816477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Baimbridge C; Davis BR; Barzilay J; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
    Am J Kidney Dis; 2008 Sep; 52(3):412-24. PubMed ID: 18676075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).
    Margolis KL; Dunn K; Simpson LM; Ford CE; Williamson JD; Gordon DJ; Einhorn PT; Probstfield JL;
    Am Heart J; 2009 Dec; 158(6):948-55. PubMed ID: 19958861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    Margolis KL; Davis BR; Baimbridge C; Ciocon JO; Cuyjet AB; Dart RA; Einhorn PT; Ford CE; Gordon D; Hartney TJ; Julian Haywood L; Holtzman J; Mathis DE; Oparil S; Probstfield JL; Simpson LM; Stokes JD; Wiegmann TB; Williamson JD;
    J Clin Hypertens (Greenwich); 2013 Aug; 15(8):542-54. PubMed ID: 23889716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.
    Han BH; Sutin D; Williamson JD; Davis BR; Piller LB; Pervin H; Pressel SL; Blaum CS;
    JAMA Intern Med; 2017 Jul; 177(7):955-965. PubMed ID: 28531241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the month. The ALLHAT-LLT trial].
    Kulbertus H; Scheen AJ
    Rev Med Liege; 2003 Jan; 58(1):53-8. PubMed ID: 12647600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALLHAT-LLT: questions, questions, and more questions (and some answers).
    Skerrett PJ; Pasternak RC
    Curr Atheroscler Rep; 2004 Sep; 6(5):375-80. PubMed ID: 15296704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
    Sacks FM; Tonkin AM; Craven T; Pfeffer MA; Shepherd J; Keech A; Furberg CD; Braunwald E
    Circulation; 2002 Mar; 105(12):1424-8. PubMed ID: 11914249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
    Deedwania PC; Stone PH; Fayyad RS; Laskey RE; Wilson DJ
    Drugs Aging; 2015 Dec; 32(12):1055-65. PubMed ID: 26625880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
    Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
    Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
    Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
    Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
    Sponseller CA; Morgan RE; Kryzhanovski VA; Campbell SE; Davidson MH
    Clin Ther; 2014 Aug; 36(8):1211-22. PubMed ID: 24998014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
    Maitland-van der Zee AH; Boerwinkle E; Arnett DK; Davis BR; Leiendecker-Foster C; Miller MB; Klungel OH; Ford CE; Eckfeldt JH
    Am Heart J; 2007 Jan; 153(1):54-8. PubMed ID: 17174637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.